Cytokine Market to show growth with industry’s leading players like Glaxosmithkline, Novartis International Ag, Roche Holding Ag, Pfizer, Sanofi SA, Bayer Healthcare through 2023

The Cytokine Market is expected to witness a CAGR of 7.9% during the forecast period. North America dominate the global market due to the increasing prevalence of cancer in that region.

Increased Acceptance in Cancer Therapy

Cytokines are critical for tumor immune surveillance, and have demonstrated therapeutic anti-tumor activity in murine models and in the clinical treatment of several human cancers. To date, two cytokines have FDA approval as single agents for cancer treatment: high-dose, bolus IL-2 for metastatic melanoma and renal cell carcinoma and IFN-α for the adjuvant therapy of Stage III melanoma. So, increased acceptance in cancer therapy is driving market of Global Cytokine Market. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Mesenchymal stem cells (MSCs) have emerged as major new cell technology, with a diverse spectrum of potential clinical applications. So, its potential contribution in stem cell therapy is also driving the Global Cytokine Market.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/15676

Key Developments in the Market

October 2017: Janssen announced US FDA approval of Stelara (ustekinumab) for the treatment of adolescents with moderate-to-severe plaque psoriasis
September 2017: Bayer received FDA approval for Copanlisib in adults for relapsed follicular lymphoma, under the brand name ‘Aliqopa’
September 2017: Roche received European approval for Actemra/RoActemra for the treatment of giant cell arteritis

Major Players:

Glaxosmithkline, Novartis International Ag, Roche Holding Ag, Pfizer Inc., Sanofi SA, Bayer Healthcare, Thermo Fisher Scientific, Biocon Limited, Bio-Techne Corporation, Abbvie Inc and Johnson & Johnson, among others.

Request Discount on this repots @ https://marketprognosis.com/discount-request/15676

Short Half-Lives of Drug

Cytokines have inherently short half-life, which necessitates prolonged administration of cytokine therapies. This is a major problem in maintaining an effective dose over a long period. This becomes an even greater issue when cytokine is administered systematically. The short half-life of cytokines, the production of cytokines by cells in peripheral blood preparations, and the potential degradation make the stability, treatment, and storage of biological samples important factors in circulating cytokine measurement, analysis, and interpretation.

Additionally, lacks of specificity in cytokines is also restraining the growth of Global Cytokine Market.

North America is dominating the market

North America is dominating the cytokine market due to the rising prevalence of cancer in that region. Numerous animal tumor model studies have demonstrated that cytokines have broad anti-tumor activity and this has been translated into a number of cytokine-based approaches for cancer therapy. As per the Cancer Statistics in 2016, an estimated 1.6 million new cases of cancer were diagnosed in the United States, with prevalence expected to rise to almost 19 million by 2024. Augmenting growth in the R&D of cancer therapy, along with lesser side effects (as compared to chemotherapy) have predisposed cytokine therapy, which is a non-specific immunotherapy. This factor has increased the market share of cytokines, among cancer therapies in the United States.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/15676

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.